The frequency of latent prostate carcinoma in autopsies of over 50 years old males, the Iranian experience

Medical Journal of the Islamic Republic of Iran

Volumn 26, Issue 2, 2012, Pages 73-77

  Zare Mirzaie, Ali ^a   Balvayeh, Payam ^b   Imamhadi, Mohammad Ali ^c   Lotfi, Maryam ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Tehran Forensic Medicine   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autopsy; Cancer; Iran; Prevalence; Prostate

Indexed keywords

EID: 84865101964     PISSN: 10161430     EISSN: 22516840     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-1427
2. Nicolas B. Delongchamps, Amar Singh and Gabriel P. Haas. The Role of Prevalence in the Diagnosis of Prostate Cancer. Cancer Control July 2006, Vol. 13, No. 3,158-168
3. Sadjadi A, Nooraie M, Ghorbani A, Alimohammadian M, Zahedi MJ, Darvish-Moghadam S, et al. The incidence of prostate cancer in Iran: results of a population-based cancer registry. Arch Iran Med 2007 Oct;10(4):481-5.
4. Montironi R, Mazzucchelli R, Algaba F, Lopez-Beltran A Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance. J Clin Pathol 2000; 53: 655-65.
5. Safarinejad MR. Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Int Urol Nephrol 2008; 40: 921-31
6. Stamatiou K, Alevizos A, Perimeni D, Sofras F, Agapitos E. Frequency of impalpable prostate adenocarcinoma and precancerous conditions in Greek male population: an autopsy study. Prostate Cancer Prostatic Dis 2006;9(1):45-9.
7. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Cancer J Clin 2005;55:74-108.
8. Yu H, Harris RE, Gao YT, Gao R, Wynder EL. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus United States. Int J Epidemiol 1991;20:76-81.
9. Gu F. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China. Chin Med J (Engl) 2000;113:299-302.
10. Yi-Ping Zhu, Ding-Wei Ye, Xu-Dong Yao, Shi-Lin Zhang, Bo Dai, Hai-Liang Zhang, et al. Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries. Asian Journal of Andrology 2009; 11: 104-108.
11. Matzkin H, Soloway MS. Cigarette smoking: a review of possible associations with benign prostatic hyperplasia and prostate cancer. Prostate 1993; 22:277-290.
12. Shiraishi T, Watanabe M, Matsuura H, Kusano I, Yatani R, Stemmermann GN. The frequency of latent prostatic carcinoma in young males: the Japanese experience. In Vivo 1994;8:445-447.
13. Sánchez-Chapado M, Olmedilla G, Cabeza M, Donat E and Ruiz A. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate 2003;54:238-247.
14. Koug XT, Xia TL, Gu FL. Study of the latent carcinoma of prostate in China. BJU 1997;80(suppl 2):A895.
15. Lee SH, Chang PL, Chen SM, Sun GH, Chen CL, Shen BY, et al. Synchronous primary carcinomas of the bladder and prostate. Asian J Androl 2006; 8: 357-9.
16. Liu R, Shao GX, Qin RL, FX K. Coexistence of transitional cell carcinoma of bladder and adenocarcinoma of prostate (report of 5 cases). Chin J Urol 1996; 17: 738-9.
17. Desai SB, Borges AM. The prevalence of highgrade prostatic intraepithelial neoplasia in surgical resection specimens: an Indian experience. Cancer 2002; 94: 2350-2.
18. Hosseini SY, Danesh AK, Parvin M, Basiri A, Javadzadeh T, Safarinejad MR et al. Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men. Int Braz J Urol 2007; 33: 167-73; Discussion 73-5.